Progress in bladder cancer monitoring bodes well for Cellmid
Cellmid launch hair loss product to vast US market
Cellmid records highest ever quarterly sales for Evolis®
Cellmid MK antibodies effective in brain cancer trials
New research backs CDY’s MK plan for osteoporosis
CDY’s midkine antibody shown to accelerate bone fracture healing
Cellmid launches hair care products in Australia
Connect with us
